【発明の名称】プロテアーゼ阻害剤としての新規化合物および組成物

Japanese Patent JP2003525874

A

The present invention relates to novel cysteine protease inhibitors of Formula I:the pharmaceutically acceptable salts and N-oxide derivatives thereof, their use as therapeutic agents and methods of making them.

JP2854308	INDUSTRIAL APPLICABILITY: Rust-proof / corrosion-proof antifreeze base material, rust-proof / corrosion-proof synthetic lubricant, and rust-proof / corrosion-proof water-containing liquid.
JP2003533519	INDUSTRIAL APPLICABILITY: Cyclohexane derivative and its use as a therapeutic agent.
WO/2007/067575	PROCESS FOR PREPARING SUBSTITUTED ARYL CYCLOALKANOL DERIVATIVES

Oberiya, Renata Marcella
Prasit, Petsupibun
Robixyo, Jjoel Stephanu
Isabel, Elise
Mendonka, Lohan Buoy
Benkatraman, Shyankar
Setu Tei, Ed Waldo
One, Dan-Syon

JP2001549656A

September 02, 2003

January 05, 2001

Click for automatic bibliography generation  

Merck Frost Canada and Company
AXYS PHARMACEUTICALS, INC.

C07D295/08; A61K31/192; A61K31/197; A61K31/275; A61K31/357; A61K31/381; A61K31/40; A61K31/401; A61K31/404; A61K31/415; A61K31/4172; A61K31/42; A61K31/426; A61K31/437; A61K31/44; A61K31/4402; A61K31/4409; A61K31/4465; A61K31/47; A61K31/472; A61K31/495; A61K31/505; A61K31/5375; A61P1/02; A61P13/12; A61P19/02; A61P19/10; A61P21/04; A61P29/00; A61P33/06; A61P35/00; A61P43/00; C07C255/25; C07C255/29; C07C255/41; C07D207/08; C07D207/14; C07D209/08; C07D209/14; C07D209/16; C07D209/30; C07D209/42; C07D211/34; C07D213/38; C07D213/56; C07D213/61; C07D213/74; C07D215/12; C07D217/12; C07D231/12; C07D233/64; C07D239/26; C07D239/42; C07D261/08; C07D263/22; C07D265/30; C07D277/20; C07D277/30; C07D277/36; C07D277/40; C07D277/42; C07D277/46; C07D277/48; C07D277/58; C07D277/68; C07D295/14; C07D295/155; C07D295/22; C07D319/16; C07D319/18; C07D333/24; C07D333/34; C07D417/04; C07D471/04; (IPC1-7): C07C255/29; A61K31/192; A61K31/197; A61K31/275; A61K31/357; A61K31/381; A61K31/40; A61K31/401; A61K31/404; A61K31/415; A61K31/4172; A61K31/42; A61K31/426; A61K31/437; A61K31/44; A61K31/4402; A61K31/4409; A61K31/4465; A61K31/47; A61K31/472; A61K31/495; A61K31/505; A61K31/5375; A61P1/02; A61P13/12; A61P19/02; A61P19/10; A61P21/04; A61P29/00; A61P33/06; A61P35/00; A61P43/00; C07D207/14; C07D209/08; C07D209/14; C07D209/16; C07D209/42; C07D213/38; C07D213/56; C07D213/74; C07D215/12; C07D217/12; C07D231/12; C07D233/64; C07D239/26; C07D261/08; C07D265/30; C07D277/30; C07D277/42; C07D277/46; C07D295/08; C07D295/14; C07D295/22; C07D319/16; C07D333/24; C07D471/04

Yoshio Kawaguchi (4 outside)

Previous Patent: タブレット化増粘系

Next Patent: 縮合ピロール化合物、それを含有してなる医薬組成物、およびその用途